Clinical Trial Update: Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and pharmacokinetics of INX-08189 in treatment-naïve adults chronically infected with hepatitis C (Genotype 1) has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• INX-08189

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HCV (Genotype 1) | Phase 1 | Status: COMPLETED